Tanya L. Kowalczyk Mullins, MD, MS

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-636-4681

Fax 513-636-7844



Adolescent medicine; adolescent gynecology; contraception; sexually transmitted infections


Prevention of sexually transmitted infections and HIV

Tanya L. Kowalczyk Mullins, MD, MS, is an adolescent medicine specialist and clinical researcher. Her primary research interest is prevention of human immunodeficiency virus (HIV) infection and other sexually transmitted infections (STIs) among adolescents. Her current research focuses on biomedical prevention of HPV using the HPV vaccine and prevention of HIV through the use of new biomedical HIV prevention methods among youth. Her currently funded work examines the role of clinicians in the uptake of HIV and other STI prevention methods. She has active collaborations with several other researchers at Cincinnati Children’s Hospital Medical Center and at other academic institutions around the country.

BS: Winthrop University, Rock Hill, SC, 1997.

MD: Medical University of South Carolina, Charleston, SC, 2001.

Residency: Vanderbilt Children's Hospital, Nashville, TN, 2004.

Fellowship: Cincinnati Children's Hospital, Cincinnati, OH, 2007.

MS: Master of Science, Epidemiology/Clinical Research, University of Cincinnati, Cincinnati, OH, 2008.

Certification: American Board of Pediatrics, General Pediatrics, 2004; American Board of Pediatrics, Adolescent Medicine, 2008.

View PubMed Publications

Patterson-Rose S, Mullins TL, Hesse EA, Lehmann C, Widdice LE. Changes in syphilis testing and infection among adolescents at an adolescent clinic. Sexual Health. In press. 2015 Apr 7.

Mullins TL, Widdice LE, Rosenthal SL, Zimet GD, Kahn JA. Risk perceptions, sexual attitudes, and sexual behavior after HPV vaccination in 11-12 year-old girls. Vaccine. 2015;33:3907–3912.

Mullins TL, Lally M, Zimet G, Kahn JA and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Clinician Attitudes toward CDC Interim Pre-Exposure Prophylaxis (PrEP) Guidance and Operationalizing PrEP for Adolescents. AIDS Patient Care STDs. 2015;29(4):193-203.

Mayhew A, Mullins TL, Ding L, Rosenthal S, Zimet G, Morrow C, Kahn JA. Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics. 2014;133(3):404-11.

Mullins TL, Griffioen AM, Glynn S, Zimet GD, Rosenthal SL, Fortenberry JD, Kahn JA. HPV vaccine communication: perspectives of 11-12 year-old girls, mothers, and clinicians. Vaccine. 2013;31(42):4894-4901.

Mullins TL, Rudy BJ, Wilson CM, Sucharew H, Kahn JA. Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the United States. Int J STD AIDS. 2013;24:123-127.

Mullins TL, Wilson CM, Rudy BJ, Sucharew H, Kahn JA. Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States. Sex Transm Dis. 2013;40(9):715-720.

Mullins TL, Zimet G, Rosenthal SL, Morrow C, Ding L, Shew ML, Fortenberry JD, Bernstein DI, Kahn JA. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med. 2012;166(1):82-88.

Mullins TL, Kollar LM, Lehmann C, Kahn JA. Changes in human immunodeficiency virus testing rates among urban adolescents after introduction of routine and rapid testing. Arch Pediatr Adolesc Med. 2010;164(9):870-874.

Kowalczyk Mullins TL, Braverman PK, Dorn LD, Kollar LM, Kahn JA. Adolescent preferences for human immunodeficiency virus testing methods and impact of rapid tests on receipt of results. J Adolesc Health. 2010;46(2):162-168.

Physician Attitudes toward New Biomedical HIV Prevention Interventions in Youth. Principal Investigator. Mentored Patient-Oriented Research Career Development Award (K23), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). 2013-2018.

ATN 111 Follow Up Study: Clinician Attitudes and Behaviors Regarding Use of Pre-exposure Prophylaxis (PrEP) for Primary HIV Prevention after Experience with a PrEP Demonstration Project among Adolescents. Adolescent Trials Network for HIV/AIDS Interventions. 2015-2016.